Status:
NOT_YET_RECRUITING
Psoas Muscle Index (PMI) as a Predictor of Outcomes After Minimally Invasive Cardiac Surgery
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Sarcopenia
Heart Valve Diseases
Eligibility:
All Genders
65-99 years
Brief Summary
Sarcopenia or muscle loss and function is a component of the frailty syndrome. In this sense, frailty is becoming an important risk factor in predicting outcomes after major surgery and is defined as ...
Detailed Description
This is a prospective, controlled, observational single-centre study of patients undergoing minimally invasive heart valve surgery at the department of minimally invasive cardiac surgery of the IRCCS ...
Eligibility Criteria
Inclusion
- Elderly patients (≥ 65 years old)
- Able to take consent
- Listed for minimally invasive cardiac surgery
- Elective and urgent procedures included
- Able to undergo MRI
Exclusion
- Full median sternotomy approach
- Emergency procedures
- Unable to take consent
- Unable to undergo MRI
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06571643
Start Date
September 1 2024
End Date
December 1 2025
Last Update
August 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Milan, Italy, 20173